treatment | Page 34 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

treatment

Ocular GVHD - Diagnosis and Treatment

In this webinar, Dr. Sandeep Jain will discuss the diagnosis and treatment of ocular GvHD which occurs in 40-60% patients following an allogenic transplant. Ocular GVHD may lead to severe ocular surface disease, which can significantly diminish quality of life and restrict daily activities. He will answer questions from participants at the end of the presentation.

Jadee Neff, M.D., Ph.D., FCAP

Neff, Jadee
Assistant Professor of Pathology
Duke Cancer Center

Dr. Jadee Neff  is a board-certified Pathologist who sees patients at Duke Cancer Center, Duke University Hospital and Duke Eye Center. She obtained her MD and PhD degrees at the Mayo Clinic College of Medicine and did her AP/CP pathology residency at Mayo Clinic.  As a diagnostic hematopathologist and molecular genetic pathologist, her clinical interests are focused on the histologic examination of tissue and